Search results
ESCMID 2024: Cutting-edge vaccines in development for a healthier tomorrow
Clinical Trials Arena via Yahoo Finance· 6 days agoThe R21/Matrix-M vaccine, developed by Oxford University and the Serum Institute of India,...
Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know
Zacks via Yahoo Finance· 6 days agoIn the latest trading session, Novavax (NVAX) closed at $4.33, marking a +0.93% move from the...
The path to a better Tuberculosis vaccine runs through Montana
Daily Montanan via Yahoo News· 3 days agoA team of Montana researchers is playing a key role in the development of a more effective vaccine...
Path to a better tuberculosis vaccine runs through Montana
Arizona Daily Sun· 2 days agoA team of Montana researchers is playing a key role in the development of a more effective vaccine against tuberculosis, an infectious disease that has killed more people ...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 5 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Flu vs COVID: Stark Disparity in Vaccination and Deaths
Medscape· 5 days agoIn the first half of 2023, COVID-19 killed 42,670 people in the United States, while the flu killed...
Small Business - Shelby County Reporter | Shelby County Reporter
The Shelby County Reporter· 4 days agoBrooklyn, New York, May 03, 2024 (GLOBE NEWSWIRE) -- According to a new market research report published by Global Market Estimates, the global biomaterial-based vaccines ...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 6 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...